Autoantigen components recognizable by scleroderma sera are exported via ectocytosis of fibroblasts

British Journal of Rheumatology

Volumn 36, Issue 10, 1997, Pages 1038-1044

  Hsu, T C ^a   Lee, T L ^a   Tsay, G J ^a  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Annexin I; Autoantigens; Ectocytosis; Fibroblasts; Scleroderma; Stress relaxation method; Topoisomerase I

Indexed keywords

ANNEXIN; AUTOANTIGEN; CELL PROTEIN; DNA TOPOISOMERASE; POLYCLONAL ANTIBODY; POLYPEPTIDE;

ARTICLE; AUTOIMMUNITY; CELL MEMBRANE TRANSPORT; CONTROLLED STUDY; FEMALE; FIBROBLAST CULTURE; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MAJOR CLINICAL STUDY; MALE; MEMBRANE VESICLE; MOLECULAR WEIGHT; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; SCLERODERMA; SEROLOGY; SYSTEMIC SCLEROSIS;

EID: 0030681409     PISSN: 02637103     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/36.10.1038     Document Type: Article

References (26)

1. Tan EM. Antinuclear antibodies: Diagnostic markers for autoimmune diseases and probes for cell biology. Adv Immunol 1989;44:93-151.
2. Tan EM. Autoantibodies in pathology and cell biology. Cell 1991;67:841-2.
3. Casciola-Rosen LA, Anhalt G, Rosen A. Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J Exp Med 1994;179:1317-30.
4. LeRoy EC. A brief overview of the pathogenesis of scleroderma (systemic sclerosis). Ann Rheum Dis 1992;51:286-8.
5. Tan EM. Autoantibodies to nuclear antigens (ANA): their immunology and medicine. Adv Immunol 1982;33:167-240.
6. Casiano CA, Landberg G, Ochs RL, Tan EM. Autoantibodies to a novel cell cycle-regulated protein that accumulates in the nuclear matrix during S phase and is localized in the kinetochores and spindle midzone during mitosis. J Cell Sci 1993;106:1045-56.
7. Casciola-Rosen LA, Anhalt G, Rosen A. DNA-dependent protein kinase is one of a subset of autoantigens specifically cleaved early during apoptosis. J Exp Med 1995;182:1625-34.
8. Stein JM, Luzio JP. Ectocytosis caused by sublytic autologous complement attack on human neutrophils. Biochem J 1991;274:381-6.
9. Cooper DNW, Barondes SH. Evidence for export of a muscle lectin from cytosol to extracellular matrix and for a novel secretory mechanism. J Cell Biol 1990; 110:1681-91.
10. Lee TL, Lin YC, Mochitate K, Grinnell F. Stress-relaxation of fibroblasts in collagen matrices triggers ectocytosis of plasma membrane vesicles containing actin, annexing II and VI, and β1 integrin receptors. J Cell Sci 1993;105:167-77.
11. Slavkin HC, Croissant RD, Bringas P, Matosian P, Wilson P, Mino W et al. Matrix vesicle heterogeneity: possible morphogenetic functions for matrix vesicles. Fed Proc 1976;35:127-34.
12. Tsay GJ, Fann RH, Hwang J. Specificity of anti-Scl-70 antibodies in scleroderma: increased sensitivity of detection using purified DNA topoisomerase I from calf thymus. J Rheumatol 1990;17:1314-9.
13. Hirata F, del Carmine R, Nelson CA, Axelrod J, Schiffmann E, Warabi A et al. Presence of autoantibody for phospholipase inhibitory protein, lipomodulin, in patients with rheumatic diseases. Proc Natl Acad Sci USA 1981;78:3190-4.
14. Goulding NJ, Podgorski MR, Hall ND, Flower RJ, Browning JL, Pepinsky RB et al. Autoantibodies to recombinant lipocortin-1 in rheumatoid arthritis and systemic lupus erythematosus. Ann Rheum Dis 1989;48:843-50.
15. Kraus M, Romisch J, Bastian B, Paques EP, Hartmann AA. Detection of human anti-annexin auto-antibodies by enzyme immunoassay. J Immunoassay 1992;13:411-39.
16. Misaki Y, Pruijn GJ, van der Kemp AW, Venrooij WJ. The 56K autoantigen is identical to human annexin XI. J Biol Chem 1994;269:4240-6.
17. Gouldner HH, Szostecki C, Vosberg H, Lakomek HJ, Penner E, Bautz FA. Scl-70 autoantibodies from scleroderma patients recognize a 95 kDa protein as DNA topoisomerase I. Chromosoma 1986;94:132-8.
18. Shero JH, Bordwell B, Rothfield NF, Earnshaw WC. High titers of autoantibodies to topoisomerase I (scl-70) in sera from scleroderma patients. Science 1986; 231:737-40.
19. Zhang, H, Wang JC, Liu LF. Involvement of DNA topoisomerase I in transcription of human ribosomal RNA genes. Proc Natl Acad Sci USA 1988;85:1060-4.
20. Fox JEB, Austin CD, Boyles JK, Steffan PK. Role of the membrane skeleton in preventing the shedding of procoagulant-rich microvesicles from the platelet plasma membrane. J Cell Biol 1990;111:483-93.
21. Wiedmer T, Shattil SJ, Cunningham M, Sims PJ. Role of calcium and calpain in complement induced vesiculation of the platelet plasma membrane and in the exposure of the platelet factor Va receptor. Biochemistry 1990;29:623-32.
22. Chen WT. Mechanism of retraction of the trailing edge during fibroblast movement. J Cell Biol 1981;90:187-200.
23. Anderson HC. Mineralization by matrix vesicles. Scanning Electron Microsc 1984;2:953-64.
24. Wu LNF, Genge BR, Wuthier RE. Evidence for specific interactions between matrix vesicle proteins and the connective tissue matrix. Bone Miner 1992; 17:247-52.
25. Genge B, Cao X, Wu LNY, Wuthier RE. Establishment of the primary structure of the two major matrix vesicle annexins by peptide and DNA sequencing. Bone Miner 1992;17:202-8.
26. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992;119:493.